Smoking Linked to Cryptogenic Ischemic Stroke in Young Adults

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 24, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, Feb. 24, 2025 -- Smoking and high-intensity smoking are associated with cryptogenic ischemic stroke (CIS) among adults aged 18 to 45 years, according to a study published online Feb. 19 in Neurology Open Access.

Phillip Ferdinand, M.B.Ch.B., from University Hospitals of North Midlands NHS Trust in the United Kingdom, and colleagues prospectively recruited patients aged 18 to 49 years with CIS within two weeks of symptom onset from 19 European stroke centers to determine the association between smoking and young CIS.

The analysis included 546 young patients with CIS and matched controls. The researchers found a significant difference between patients and controls in low education status, hypertension, obesity, physical inactivity, smoking, and heavy alcohol use. In the whole cohort, there was an association between smoking and young CIS after adjustment (odds ratio, 2.39), with stronger associations seen in men (odds ratio, 3.34). The association was seen in all age groups and was highest in the 45- to 49-year-old age group (odds ratio, 3.77). The strongest association was seen for those with >20 pack-years (odds ratio, 4.30), especially in men and in the 45- to 49-year-old age group.

"We found a clear association between smoking and CIS in the young even after adjustment for low education status and well-known vascular risk factors," the authors write. "This association was strong in men but was not significant in women."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-02-25 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords